Simplex Trading, LLC Generation Bio Co. Transaction History

Simplex Trading, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 25, 2024	SELL	$2.64 - $4.35 $65,788 - $108,401	-24,920 Reduced 99.31%	172 $0
Q1 2024 Apr 25, 2024	BUY	$1.73 - $4.07 $21,237 - $49,963	12,276 Added 95.79%	25,092 $102,000
Q4 2023 Feb 02, 2024	BUY	$0.91 - $3.35 $11,248 - $41,409	12,361 Added 2716.7%	12,816 $21,000
Q3 2023 Nov 01, 2023	BUY	$3.65 - $6.9 $835 - $1,580	229 Added 101.33%	455 $1,000
Q2 2023 Aug 04, 2023	SELL	$3.5 - $5.67 $80 - $130	-23 Reduced 9.24%	226 $1,000
Q1 2023 Apr 27, 2023	BUY	$3.61 - $7.01 $898 - $1,745	249 New	249 $1,000
Q1 2022 May 02, 2022	SELL	$4.16 - $7.76 $19,443 - $36,270	-4,674 Closed	0 $0
Q4 2021 Feb 23, 2022	SELL	$5.99 - $24.97 $109,952 - $458,349	-18,356 Reduced 79.7%	4,674 $33,000
Q3 2021 Oct 28, 2021	SELL	$20.0 - $27.43 $27,360 - $37,524	-1,368 Reduced 5.61%	23,030 $631,000
Q2 2021 Aug 12, 2021	SELL	$24.34 - $38.34 $769,922 - $1.21 Million	-31,632 Reduced 56.46%	24,398 $656,000
Q1 2021 Apr 26, 2021	BUY	$24.74 - $40.2 $1.39 Million - $2.25 Million	56,030 New	56,030 $1.59 Million

49.5M

Ticker GBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,011,200
Market Cap $47.8M
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was f...

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Simplex Trading, LLC with notifications on news.